Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis

NCT00029107 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

NIH

Sponsor class

Conditions

Hepatitis C
Vasculitis

Interventions

DRUG: Rituximab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)